| 英文別名 |
Doramectin;25-CYCLOHEXYL-5-O-DEMETHYL-25-DE(1-METHYLPROPYL)AVERMECTIN;Doramectin VETRANAL;Doromectin;bridged fused ring systems nomenclature: (2aE,4E,8E)-(5’S,6S,6’R,7S,11R,13S,15S,17aR,20R,20aR,20bS)-6’-cyclohexyl-5’,6,6’,7,10,11,14,15,17a,20,20a,20b-dodecahydro-20,20b-dihydroxy-5’,6,8,19-tetramethyl-17-oxospiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside;DONGGUAI;Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran],avermectin A1a deriv.;25-Cyclohexylavermectin B1;Dectomax;L701023;UK 67994;KGD7A54H5P;Doramectinum [INN-Latin];Doramectine [INN-French];Doramectina [INN-Spanish];Doramectin [USAN:INN:BAN];Doramectine;Doramectinum;Doramectina;C50H74O14;UK 67,994;Cyclohexylavermectin B1;DSSTox_RID_83176;DSSTox_CID_28908;DSSTox_GSID_48982;Avermectin A(sub 1a), 25-cycloh |
應(yīng)用領(lǐng)域 |
|
